Moclobemide

Results: 37



#Item
21FROVA® (frovatriptan succinate) Tablets DESCRIPTION FROVA (frovatriptan succinate) tablets contain frovatriptan succinate, a selective 5-hydroxytryptamine1 (5-HT1B/1D) receptor subtype agonist, as the active ingredient.

FROVA® (frovatriptan succinate) Tablets DESCRIPTION FROVA (frovatriptan succinate) tablets contain frovatriptan succinate, a selective 5-hydroxytryptamine1 (5-HT1B/1D) receptor subtype agonist, as the active ingredient.

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-04-21 16:03:02
22LACHMANCONSULTANTSERVICF.S,lNC. Westbury, NY[removed]ATTACHMENT  2

LACHMANCONSULTANTSERVICF.S,lNC. Westbury, NY[removed]ATTACHMENT 2

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2004-12-01 13:58:11
23Appendix D: Switching Antidepressants Switching antidepressants can be accomplished by the following strategies: 1.	 Direct switch: stop the first antidepressant abruptly and start new antidepressant the next day. 2.	 Ta

Appendix D: Switching Antidepressants Switching antidepressants can be accomplished by the following strategies: 1. Direct switch: stop the first antidepressant abruptly and start new antidepressant the next day. 2. Ta

Add to Reading List

Source URL: www.bcguidelines.ca

Language: English - Date: 2014-03-03 17:18:50
24Appendix C: First-Line Antidepressants “First-line” antidepressant treatment represents a balance of efficacy, tolerability and expert consideration per the Canadian Network for Mood and Anxiety Treatments (CANMAT) r

Appendix C: First-Line Antidepressants “First-line” antidepressant treatment represents a balance of efficacy, tolerability and expert consideration per the Canadian Network for Mood and Anxiety Treatments (CANMAT) r

Add to Reading List

Source URL: www.bcguidelines.ca

Language: English - Date: 2014-03-03 17:18:50
25Antidepressant Medicines An Easy-to-Read Guide For People Who Take These Medicines

Antidepressant Medicines An Easy-to-Read Guide For People Who Take These Medicines

Add to Reading List

Source URL: nisonger.osu.edu

Language: English - Date: 2012-04-10 12:52:00
26These highlights do not include all the information needed to use AXERT safely and effectively. See full prescribing information for AXERT. AXERT® (almotriptan malate) TabletsInitial U.S. Approval: 2001

These highlights do not include all the information needed to use AXERT safely and effectively. See full prescribing information for AXERT. AXERT® (almotriptan malate) TabletsInitial U.S. Approval: 2001

Add to Reading List

Source URL: www.fda.gov

Language: English
27Appendix A. Preclinical Summary  Appendix A, page 1 of 39 Nonclinical Pharmacology, ADME, and Toxicology Summary Table of Contents

Appendix A. Preclinical Summary Appendix A, page 1 of 39 Nonclinical Pharmacology, ADME, and Toxicology Summary Table of Contents

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2000-03-23 04:08:32
28Revised: [removed]Axert® (almotriptan malate) Tablets ----------------------------------DRUG INTERACTIONS--------------------------------•	 Do not use AXERT® and ergotamine-containing or ergot-type medication

Revised: [removed]Axert® (almotriptan malate) Tablets ----------------------------------DRUG INTERACTIONS--------------------------------• Do not use AXERT® and ergotamine-containing or ergot-type medication

Add to Reading List

Source URL: www.axert.com

Language: English - Date: 2012-12-06 16:24:22
29EU PSUR Work Sharing Summary Assessment Report Zomig, Zomig Rapimelt, Zomig Nasal (zolmitriptan) SE/H/PSUR[removed]P-RMS

EU PSUR Work Sharing Summary Assessment Report Zomig, Zomig Rapimelt, Zomig Nasal (zolmitriptan) SE/H/PSUR[removed]P-RMS

Add to Reading List

Source URL: www.hma.eu

Language: English - Date: 2014-06-03 10:34:25
30[removed]Summary AR moclobemide

[removed]Summary AR moclobemide

Add to Reading List

Source URL: www.hma.eu

Language: English - Date: 2014-05-06 06:23:38